Loading...
VolitionRx Limited
VNRX•AMEX
Healthcare
Medical - Diagnostics & Research
$0.73
$-0.02(-2.63%)
VolitionRx Limited (VNRX) Financial Performance & Income Statement Overview
Review VolitionRx Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
59.10%
↑ 59.10%
Operating Income Growth
24.90%
↑ 24.90%
Net Income Growth
23.65%
↑ 23.65%
Operating Cash Flow Growth
-43.35%
↓ 43.35%
Operating Margin
-1424.72%
↓ 1424.72%
Gross Margin
31.67%
↑ 31.67%
Net Profit Margin
-1836.21%
↓ 1836.21%
ROE
108.006%
↑ 108.006%
ROIC
-7548.03%
↓ 7548.03%
VolitionRx Limited (VNRX) Income Statement & Financial Overview
Review VolitionRx Limited's (VNRX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $191657.00 | $474522.00 | $395797.00 | $171535.00 |
| Cost of Revenue | $323875.00 | $0.00 | $323797.00 | $322073.00 |
| Gross Profit | -$132218.00 | $474522.00 | $72000.00 | -$150538.00 |
| Gross Profit Ratio | -$0.69 | $1.00 | $0.18 | -$0.88 |
| R&D Expenses | $2.59M | $3.47M | $3.72M | $4.37M |
| SG&A Expenses | $3.33M | $2.87M | $3.62M | $3.87M |
| Operating Expenses | $5.97M | $6.34M | $7.06M | $8.23M |
| Total Costs & Expenses | $5.97M | $6.34M | $7.39M | $8.56M |
| Interest Income | $313.00 | $530.00 | $450.00 | $8654.00 |
| Interest Expense | $92491.00 | $89456.00 | $81182.00 | $77233.00 |
| Depreciation & Amortization | $352117.00 | $341277.00 | $323465.00 | $322073.00 |
| EBITDA | -$5.41M | -$5.45M | -$6.66M | -$8.07M |
| EBITDA Ratio | -$28.24 | -$11.48 | -$16.81 | -$47.06 |
| Operating Income | -$5.78M | -$5.87M | -$6.99M | -$8.38M |
| Operating Income Ratio | -$30.17 | -$12.37 | -$17.66 | -$48.88 |
| Other Income/Expenses (Net) | -$75887.00 | $129.00 | -$69756.00 | -$87501.00 |
| Income Before Tax | -$5.86M | -$5.87M | -$7.06M | -$8.47M |
| Income Before Tax Ratio | -$30.56 | -$12.37 | -$17.84 | -$49.39 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$104620.00 |
| Net Income | -$5.79M | -$5.82M | -$6.99M | -$8.37M |
| Net Income Ratio | -$30.23 | -$12.27 | -$17.65 | -$48.78 |
| EPS | -$0.07 | -$0.07 | -$0.08 | -$0.10 |
| Diluted EPS | -$0.07 | -$0.07 | -$0.08 | -$0.10 |
| Weighted Avg Shares Outstanding | $96.10M | $87.89M | $82.67M | $81.96M |
| Weighted Avg Shares Outstanding (Diluted) | $96.10M | $87.89M | $82.67M | $81.96M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan